Published: 22 January 2016
Author(s): Maud A.W. Hermans, Mark J.A. Rietveld, Jan A.M. van Laar, Virgil A.S.H. Dalm, Maurice Verburg, Suzanne G.M.A. Pasmans, Roy Gerth van Wijk, P. Martin van Hagen, Paul L.A. van Daele
Issue: January 2016
Section: Original Article

Systemic mastocytosis (SM) is a rare heterogeneous disease which is characterized by the aberrant proliferation of mast cells. It can be divided into various subtypes with different phenotypes and prognoses. Here, we report on the clinical characteristics of 136 SM patients.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.